These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 16235179
21. Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients. Kampira E, Dzobo K, Kumwenda J, van Oosterhout JJ, Parker MI, Dandara C. OMICS; 2014 Jul; 18(7):438-45. PubMed ID: 24816082 [Abstract] [Full Text] [Related]
22. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART. Morén C, Noguera-Julian A, Rovira N, Garrabou G, Nicolàs M, Cardellach F, Martínez E, Sánchez E, Miró O, Fortuny C. Antivir Ther; 2011 Jul; 16(5):719-24. PubMed ID: 21817193 [Abstract] [Full Text] [Related]
23. Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients. Einsiedel L, Cherry CL, Sheeran FL, Friedhuber A, Wesselingh SL, Pepe S. Mitochondrion; 2010 Aug; 10(5):534-9. PubMed ID: 20685321 [Abstract] [Full Text] [Related]
24. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Clin Infect Dis; 2007 Feb 01; 44(3):447-52. PubMed ID: 17205457 [Abstract] [Full Text] [Related]
25. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients. Ciccosanti F, Corazzari M, Soldani F, Matarrese P, Pagliarini V, Iadevaia V, Tinari A, Zaccarelli M, Perfettini JL, Malorni W, Kroemer G, Antinori A, Fimia GM, Piacentini M. Antivir Ther; 2010 Feb 01; 15(3):377-90. PubMed ID: 20516557 [Abstract] [Full Text] [Related]
27. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Nolan D, Hammond E, James I, McKinnon E, Mallal S. Antivir Ther; 2003 Dec 01; 8(6):617-26. PubMed ID: 14760896 [Abstract] [Full Text] [Related]
33. Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants. Côté HC, Raboud J, Bitnun A, Alimenti A, Money DM, Maan E, Costei A, Gadawski I, Diong C, Read S, Shen S, Harrigan PR, Burdge DR, King SM, Forbes JC. J Infect Dis; 2008 Sep 15; 198(6):851-9. PubMed ID: 18684095 [Abstract] [Full Text] [Related]
36. Infection with HIV-1 induces a decrease in mtDNA. Casula M, Bosboom-Dobbelaer I, Smolders K, Otto S, Bakker M, de Baar MP, Reiss P, de Ronde A. J Infect Dis; 2005 May 01; 191(9):1468-71. PubMed ID: 15809905 [Abstract] [Full Text] [Related]
39. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Miró O, López S, Martínez E, Pedrol E, Milinkovic A, Deig E, Garrabou G, Casademont J, Gatell JM, Cardellach F. Clin Infect Dis; 2004 Sep 01; 39(5):710-6. PubMed ID: 15356787 [Abstract] [Full Text] [Related]